Novelos Therapeutics, Madison, is starting a new phase of tests of its cancer-fighting drug known as iodine-131-CLR 1404, nicknamed HOT. That means the compound will be in three separate trials at the same time at the UW Hospital Carbone Cancer Center: two to see how well it shows images of cancerous tumors and one to see how large of a dose can be tolerated to treat cancers.
MADISON - Novelos cancer drug in three trials at UW Hospital
Novelos Therapeutics, Madison, is starting a new phase of tests of its cancer-fighting drug known as iodine-131-CLR 1404, nicknamed HOT. That means the compound will be in three separate trials at the same time at the UW Hospital Carbone Cancer Center: two to see how well it shows images of cancerous tumors and one to see how large of a dose can be tolerated to treat cancers.
advertisement





This image can now be accessed by javascript as document.MyImage. Of course add in the width, height, alt, and border properties as desired too.
The next part is to create a link around that image. This will allow javascript to affect the image properties.
